Naturally Occurring Autoantibodies Against β-Amyloid
Authors:
- 1 January 2012
- book chapter
- Published by Springer Nature
- Vol. 750, 91-99
Abstract
Naturally occurring antibodies (NAbs) have been described for more than 30 years. Recently, NAbs against β-Amyloid and against other proteins involved in neurodegenerative disorders have been detected in humans. Based on the current evidence, it is hypothesized that anti-Aβ NAbs can inhibit the fibrillation and toxicity of β-aymloid, can improve cognition in a transgenic mouse model and interfere with oligomers of Aβ. Different functions of these NAbs have been described in the current literature. Based on the results of the diverse studies a Phase-III study using IVIG has been initiated in patients with AD. The results will show whether the application of NAbs will change the fate of the disease. This chapter summarizes our current knowledge on NAbs against Aβ.Keywords
This publication has 54 references indexed in Scilit:
- Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70−Journal of Experimental Medicine, 2011
- Intravenous Immunoglobulins as a Treatment for Alzheimerʼs DiseaseDrugs, 2010
- Alzheimer's disease: synaptic dysfunction and AβMolecular Neurodegeneration, 2009
- Structural Classification of Toxic Amyloid OligomersJournal of Biological Chemistry, 2008
- Peripheral and central biodistribution of 111In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's diseaseNeuroscience Letters, 2008
- Nature and functions of autoantibodiesNature Clinical Practice Rheumatology, 2008
- Peripheral B cell subsetsCurrent Opinion in Immunology, 2008
- Mechanisms of Protein Fibril Formation: Nucleated Polymerization with Competing Off-Pathway AggregationBiophysical Journal, 2008
- Immune response to Aβ-peptides in peripheral blood from patients with Alzheimer's disease and control subjectsNeuroscience Letters, 2004
- Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular ToxicityJournal of Biological Chemistry, 2002